INTRODUCTION
============

Nephrology is a medical discipline that gained autonomy in the mid-1950s, when the eminent clinician Jean Hamburger in Paris proposed this term to define the branch of internal medicine that would study kidney diseases \[[@sfy033-B1], [@sfy033-B2]\]. In the preceding decades, mainly experimental studies and clinical observations had enriched the knowledge on specific physiological aspects of renal function \[[@sfy033-B3]\], while at the time of Hamburger, a spectrum of glomerulonephritides and renal diseases with a defined pathogenesis were identified \[[@sfy033-B4], [@sfy033-B5]\]. Also, the introduction of the Kolff artificial kidney occurred a decade before, and laid the foundations for this novel branch of medicine. In recognition of the rapidly growing new discipline, prominent specialists worldwide founded the International Society of Nephrology in 1960 \[[@sfy033-B1]\]. The development of areas of interest in nephrology and its specific clinical and research topics can be analysed from the research contributions summing up about 795 000 items in the PubMed database under the heading 'kidney'. We were interested in assessing the most relevant scientific articles that influenced the nephrological practice and shaped the discipline, by focusing on specific topics of the research in kidney diseases.

In recent years, efforts have been made to define relevant articles in some medical specialty areas (anaesthesiology, dermatology, general surgery, urology, chronobiology and neurosciences) by identifying the 100 most cited articles \[[@sfy033-B6]\], and some journals have analysed the 'classic' articles published by impact on readership \[[@sfy033-B12], [@sfy033-B13]\]. No such investigation has been conducted in nephrology. We therefore employed a bibliometric analysis aimed at identifying the top 100 most cited scientific articles on specific nephrological issues.

MATERIALS AND METHODS
=====================

The Google Scholar tool, which restitutes for each article the number of citations, was used to search for the most cited articles of nephrological interest. Compared with other instruments (such as Scopus, and Web of Science by Thomson Reuters), Google Scholar is able to capture a broader spectrum of citing sources, including books, conference publications, other citations, etc. The search was conducted by introducing in the field 'with at least one of the words', general terms that could capture all relevant articles dealing with kidney function, pathology, renal pathophysiology, renal diseases, principal drugs used for kidney diseases, common comorbidities of kidney diseases, principal metabolites handled by the kidney, dialysis and transplantation. We selected all index word(s) that restituted at least 100 000 items in Google Scholar. Also, a combination of terms was used to probe the search engine and to make sure that all relevant publications could be identified.

Selected articles were original articles, meta-analyses, consensus articles and guidelines. Narrative reviews were not considered. The top most cited 100 articles were identified. A preliminary analysis of number of citations allowed us to set a cut-off of 1000 citations, so all articles that received a higher number of citations were extracted and listed to generate a rank based on absolute number of citations received by each article as of 7 February 2018. Concerning the country origin of the articles, individual countries have been listed if the authors derived from up to three countries, otherwise, the origin was deemed as global, if the countries of author origin were four or more.

Since most recent articles have a lifespan shorter than older articles, the number of citations per year was also calculated. Articles were categorized according to the topic in one of nine subfields.

RESULTS
=======

In [Table 1](#sfy033-T1){ref-type="table"}, all terms used for searching the Google Scholar database are listed. A total of 50 terms were identified that produced more than 100 000 hits in Google Scholar search. The database was then probed with each individual term listed and all publications with at least 1000 citations were extracted. Top most cited 100 articles collected cumulatively \>285 000 citations. The nine subcategories of the top 100 articles are indicated in [Table 2](#sfy033-T2){ref-type="table"}. The most populated category was 'Renal function assessment', which included 16 articles that collectively accumulated nearly 68 000 citations (almost 24% of all citations). The second most abundant group of articles belonged to the subcategory 'Randomized trials and pharmacology' (16 articles, 46 652 citations, 16.4% of all citations). Subcategories 'Dialysis/Transplantation', 'Epidemiological studies', 'Pathophysiology' and 'Acute Kidney Injury' individually accounted for about 10% of all citations and each category contained between 9 and 14 articles ([Table 2](#sfy033-T2){ref-type="table"}). Table 1.Terms used to extract relevant articles with highest citations, and number of items indexed in the Google Scholar search engine for each termNumberTermNumber of items (approx.)NumberTermNumber of items (approx.)1Clearance3 450 00026Nephrology838 0002Urine3 190 00027ACE inhibitor753 0003Urea3 040 00028Haemodialysis762 0004Kidney3 000 00029Nephropathy717 0005Renal2 900 00030Renin698 0006Urinary2 770 00031Nephritis467 0007Hypertension2 710 00032Tubular secretion458 0008Low-protein diet2 690 00033Metabolic acidosis401 0009CKD2 670 00034Kidney stones393 00010Chronic renal failure2 390 00035Glomerulonephritis389 00011End stage renal disease2 390 00036Proteinuria389 00012Renal insufficiency2 060 00037Diuretic373 00013Acid base balance2 000 00038Nephron355 00014Dialysis1 990 00039Tubular necrosis340 00015End stage kidney disease1 800 00040Renal cysts307 00016Kidney transplant1 760 00041Eclampsia278 00017Renal failure1 740 00042Nephrotic259 00018Renal transplant1 740 00043Renal glomerulus251 00019AKI1 730 00044Uraemic244 00020Renal tubular1 640 00045Haematuria199 00021Kidney transplantation1 640 00046Pyelonephritis184 00022Renal transplantation1 600 00047Diuresis183 00023Creatinine1 330 00048Furosemide176 00024Angiotensin1 320 00049Uraemia160 00025Glomerular948 00050Albuminuria123 000Table 2.Subcategories of the top 100 most cited articlesNumberArticle groupDescriptionAbbreviationNumber of articlesArticle numberNumber of citations (total)% total1Renal function assessmentStudies on modalities of renal function assessment and laboratory methodsRF161, 2, 4, 17, 19, 26, 27, 31--33, 39, 52, 56, 78, 81, 9567 93823.82Randomized trials/pharmacologyRandomized clinical trials and pharmacology of relevant kidney diseasesRT166--8, 14, 35, 36, 44, 46, 51, 57, 60, 72, 73, 87, 98, 10046 65216.43Dialysis transplantationStudies involving uraemic patients treated by dialysis or transplantationDT1424, 28, 34, 41, 45, 53, 58, 59, 62, 70, 82, 83, 88, 9029 42410.34Epidemiological studiesStudies on prevalence of renal diseases, outcomes, guidelinesES912, 13, 15, 16, 21, 30, 37, 54, 5527 7919.75PathophysiologyMechanisms of kidney diseasesPP1218, 23, 25, 29, 43, 48, 50, 63, 68, 71, 86, 9327 6139.76AKIPathogenic factors, biomarkers, classification and interventions in AKIA109, 10, 22, 38, 66, 67, 75--77, 8927 1159.57Kidney structure and functionStudies on structural, functional aspect, development of kidney and geneticsSF75, 11, 69, 74, 84, 92, 9420 2017.18CKD/pathologyPathogenic and predictive factors of CKD evolution/pathology of renal diseasesCK63, 20, 42, 65, 85, 9919 4696.99Comorbidities of renal diseaseStudies on mechanisms of diabetic nephropathy and hypertensionDH1040, 47, 49, 61, 64, 79, 80, 91, 96, 9718 8916.6Total285 094100.0
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The first most cited article dealing with issues relevant to the haemodialysis field is at the 15th position, by Wolfe *et al.,* concerning the mortality risk in patients on dialysis compared with that in transplanted patients. This article collected 3698 citations ([Table 3](#sfy033-T3){ref-type="table"}). There are 11 other articles dealing with specific issues related to chronic dialysis (at the 24th, 28th, 34th, 45th, 46th, 53rd, 58th, 62nd, 82nd, 83rd and 90th position) and these concern risk factors for mortality, atherosclerosis, mineral metabolism, aluminium intoxication, vascular access, effects of dialysis membrane type and inflammation. All the 12 articles were globally cited 27 481 times (9.6% of the total citations of the top 100 articles).

Another relevant aspect is represented by epidemiological studies on the classification and incidence of CKD in the US population (two articles by Levey and Coresh *et al.*, respectively, at rank number 12 and 13). Other articles of epidemiological interest are found at position 21st, 30th, 37th, 54th and 55th, and collectively have been cited 20 555 times (7.2% of the global citations).

A total of four studies on anaemia correction by erythropoiesis-stimulating agents are present in the top 100 list. The four articles allocate to the 35th, 36th, 57th and 60th position. Cumulative citations of these studies were 8968 (3.1% of total citations) ([Table 3](#sfy033-T3){ref-type="table"}).

Basic sciences or mechanism of diseases were addressed in some articles, namely at rank 11th \[genetic polymorphism at the angiotensin-converting enzyme (*ACE*) gene, regulating plasma levels of the enzyme\], 18th (nephrotic syndrome caused by shunt operation for hydrocephalus), 23rd (tyrosine kinase and endothelial dysfunction in pre-eclampsia), 43rd (nitric oxide accumulation in renal failure), 50th (urinary antimicrobial effects of hepcidin), 69th (kidney development), 74th (mutated nephrin and nephrotic syndrome), 84th (cellular function of polycystin 1 and 2), 86th \[von Willebrand factor and thrombotic thrmocytopenic purpura (TTP)\] and 92nd (tyrosine kinase receptor and kidney development); the number of citations for each of these articles ranged from 4225 to 1583 ([Table 3](#sfy033-T3){ref-type="table"}).

Epidemiology, classification and management of acute renal failure and AKI has received proper attention: besides the 9th and 10th article by the AKI Network, we find articles at 22nd, 38th, 66th, 67th, 75th, 76th, 77th and 89th rank. Cumulative citations of this subcategory are 27 115 (9.5% of total) ([Table 2](#sfy033-T2){ref-type="table"}).

Common comorbidities of CKD, such as diabetes and hypertension, relative to their potential to cause renal diseases were topics covered in 10 out of the top 100 articles (rank number 40, 47, 49, 61, 64, 79, 80, 91, 96 and 97): half of them focused on hypertension and half on predictive factors of diabetic nephropathy in patients affected by diabetes mellitus ([Table 3](#sfy033-T3){ref-type="table"}); all 10 articles received 6.6% of total citations ([Table 2](#sfy033-T2){ref-type="table"}).

Among the top 100 articles there were 9 'classic' articles, which were published more than 50 years ago (rank number 5, 17, 18, 29, 33, 39, 56, 62 and 94), and spanned across four categories (Kidney structure and function, Renal function assessment, Pathophysiology and Dialysis transplantation). The oldest article included in the top 100 was the 1934 article by Goldblatt in the *Journal of Experimental Medicine* describing the effect on systemic blood pressure consequent to renal ischaemia, that has been cited 2632 times since then, with a mean rate of 31.7 citations/year for a period of 83 years.

A total of 35 scientific journals had published the top 100 most cited articles in nephrology, of which eight included almost 70% of all contributions (*The New England Journal of Medicine*, *The Lancet, American Journal of Kidney Diseases*, *Kidney International*, *Annals of Internal Medicine*, *JAMA*, *Journal of Clinical Investigation* and *Journal of the American Society of Nephrology*) ([Table 4](#sfy033-T4){ref-type="table"}). Table 4.Number of articles for the different scientific journals that contributed to the top 100 most cited articles in nephrologyJournalNumber of articles*N Engl J Med*27*Lancet*10*Am J Kidney Dis*7*Kidney Int*7*Ann Intern Med*5*JAMA*5*J Clin Invest*4*J Am Soc Nephrol*4*Crit Care*2*J Biol Chem*2*Circulation*2*Br Med J*2*Clin Chem*1*Hypertension*1*Nephron*1*J Histochem Cytochem*1*J Clin Endocrinol Metab*1*Nephrol Dial Transpl*1*J Exp Med*1*Nat Biotechnol*1*Methods Enzymol*1*J Clin Pathol*1*Science*1*Pediatrics*1*Am J Physiol*1*Cell*1*Mol Cell*1*J Am Coll Cardiol*1*Am J Med*1*Nat Genet*1*Nature*1*J Am Chem Soc*1*Pediatr Clin North Am*1*Neurology*1*Arch Intern Med*1Total100

The principal author or co-author with higher number of articles in the top 100 is AS Levey with 10 articles (rank number 2, 4, 12, 13, 19, 21, 27, 30, 44 and 82) accounting for a total of 45 716 citations (16.0% of all citations).

Concerning the country of origin of the articles included in the top 100 list, the great majority of studies were contributed by USA scientists (total 62 articles), while 16 articles were contributed by authors from four or more countries (defined as global). The UK contributed seven articles and other countries (Germany, Canada, France, Australia, Italy, Denmark, Sweden and Finland) with a lower number ([Figure 1](#sfy033-F1){ref-type="fig"}). Plotting all the 100 top cited articles in a timeline graph by number of articles published and the year of publication shows that the maximum number of articles were published in 2003 (nine articles), there is a large skewness towards the old articles going back to 1934, while the most recent article was published in 2011 ([Figure 2](#sfy033-F2){ref-type="fig"}).

![Countries of origins of the articles included in the top 100 list.](sfy033f1){#sfy033-F1}

![Timeline of the articles included in the top 100 most cited.](sfy033f2){#sfy033-F2}

DISCUSSION
==========

In this study, we have evaluated the top 100 articles that had a high impact on the practice of nephrology, by assessing the number of times these articles were cited. Therefore, by analysing the topics that were covered by the set of articles, one can draw the contours of the discipline and, potentially, its evolution over time since its establishment about 60 years ago. Through this analysis, one can also obtain information on the major source of articles that contributed to the most cited and assess their country of origin.

We decided to use an approach based on Google Scholar search, which is more comprehensive of all citing sources of an article. One has to consider, however, that the cumulative number of citations in each subcategory does not reflect the global interest of the nephrology community for that specific field; instead it represents an estimation of the weight of single publications that have been produced in that specific subfield.

It is not possible to comment on each individual article included in the top 100 list; however, we can draw some considerations that help understand the major interests of the nephrological professionals worldwide.

The first two most cited articles are: (i) the 1976 article on Cockcroft--Gault formula for estimating creatinine clearance and (ii) Levey's 1999 article on estimating GFR by the Modification of Diet in Renal Disease (MDRD) formula. Both of them accumulated \>27 600 citations (9.7% of the total citations of the top 100 articles). Therefore, the highest interest of nephrologists in the last three to four decades has been related to estimating GFR in a more accurate way. As a matter of fact, at the fourth position we find the article by Levey *et al*. describing the new CKD-EPI formula for estimating GFR, while at the 27th position of most cited articles there is a 2000 abstract by Levey *et al.* on a modification of the original MDRD formula to calculate estimated GFR, which is worth of 2681 citations. Also, at the 19th rank we find the article by Levey and the CKD-EPI consortium on the expression of the MDRD formula by standardized creatinine measurement. Finally, another article by Schwartz *et al.* on estimating GFR in children, collected 2152 citations and ranked 52nd. In total, 10 articles concerned measurement of serum creatinine, and different formulas to estimate GFR by different methods or in different ethnic groups, and cumulatively they were cited 53 140 times (18.6% of total citations of the top 100 articles). This result can be, at least partially, explained by the interdisciplinary relevance of this topic.

Another relevant field of interest in nephrological research is the pharmacological intervention aimed at slowing the progression rate of CKD. At the 6th position we find a clinical trial from Brenner *et al.* about the Reduction of Endopoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) study with 7219 citations. While on the 7th and 8th positions, we find two studies from Ed Lewis\'s group on the renoprotective effects of RAAS blockade in diabetic nephropathy, which cumulatively were cited 11 707 times. It is noteworthy that a good proportion of articles describing randomized controlled trials with drugs involve antagonists of the renin-angiotensin system that have a broader organ protection in common chronic conditions such as diabetes, hypertension and cardiovascular diseases and, therefore, have a multidisciplinary interest. Even though the pharmacological intervention and randomized controlled studies do not have the proper weight in the nephrological literature, compared with other medical specialties, since 'only' 13 articles among the top 100 concerned randomized controlled trials, and the paucity of controlled studies in nephrology has been emphasized in a previous report by the Cochrane investigators \[[@sfy033-B14]\].

Among the first 10 most cited articles, 4 were published \<15 years ago, and this aspect may represent a sign of acceleration of the nephrological community on specific research topics (epidemiology of CKD, exact estimation of GFR and classification of AKI).

Correction of anaemia in uraemic patients after the introduction of erythropoiesis-stimulating agents in the late 1980s has represented a classic topic of the nephrological research. Among the top 100 articles, we find four contributions describing intervention studies evaluating the effects of recombinant human erythropoietin on correction of anaemia in end-stage renal disease patients. Aside from the original pilot study in 25 haemodialysis patients by Eschbach *et al.*, the other three studies that received significant citations in this field, addressed the issue of different targets of haemoglobin on mortality and quality of life in dialysis patients with or without cardiovascular disease, and in patients Stage 3--4 CKD.

The large prevalence of articles published in the USA among the top 100 list is not surprising, since the scientific and medical research core, starting at the beginning of the 20th century, shifted its gravitational centre from Europe to Northern America, supported by a rapid growth of public and private universities in the USA \[[@sfy033-B15]\]. Perhaps, American authors tend to cite other articles produced in that country. Also, relevant journals that are based in the USA, tend to prefer American reviewers \[[@sfy033-B7]\].

The number of citations cannot be considered the unique criterion to establish the absolute relevance of a scientific article. It perhaps reflects a measure of recognition or the way that specific contribution intersects with relevant, even though practical, issues; the number of citations is by no way a measure of the scientific or clinical quality of a specific study. Associated to this concept is the finding that, when the journal *Nature* commissioned a search from the Thomson Reuters Institute to identify the top 100 most cited scientific articles ever \[[@sfy033-B16]\], in first position was an article of practical impact in lab experiments: that is, the method for protein microassay in fluids, described by Oliver Lowry in 1951, which accumulated 305 000 citations. On the other side, the 1953 Watson and Crick article published in *Nature* about the discovery of the DNA structure, was cited, at the time of the *Nature* article was published, 'only' 5307 times \[[@sfy033-B16]\].

In conclusion, this analysis allows identification of major fields of interest in the nephrological clinical and basic research. Most relevant aspects that have been explored in the top 100 most cited articles deal with the modality of evaluation of renal function, controlled trials with pharmacologic agents useful for delaying the progression of CKDs and the epidemiological assessment of prevalence of CKDs in the general population. Specific issues pertaining to morbidity of the uraemic status and definition and management of AKI are also relevant aspects of the nephrological investigation. The relevant nephrological literature comes from English-based journals and is produced in the USA. Information from this analysis may help guide the process of scientific updating required for a proper clinical practice of the modern nephrologist.
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